Investigation of the Real World Effectiveness of Beclomethasone Dipropionate Nasal Aerosol in Perennial Allergic Rhinitis Patients

Trial Profile

Investigation of the Real World Effectiveness of Beclomethasone Dipropionate Nasal Aerosol in Perennial Allergic Rhinitis Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2015

At a glance

  • Drugs Beclometasone (Primary)
  • Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Acronyms BALANCE
  • Sponsors Teva Pharmaceutical Industries
  • Most Recent Events

    • 04 Nov 2015 Results presented at the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
    • 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top